Research experience
-
Jan 2012
Research: Johns Hopkins University
Johns Hopkins University · Department of MedicineUSA · Baltimore -
Jan 2009–
Dec 2011Research: Medical University of Ohio at Toledo
Medical University of Ohio at Toledo · Department of MedicineUSA · Toledo -
Jan 2009–
Dec 2012Research: University of Toledo
University of Toledo · Department of MedicineUSA · Toledo
Publications (49) View all
-
Article: HANDS-ON REVIEW Establishing the Mechanism of Supraventricular Tachycardia in the Electrophysiology Laboratory 1
Khalil Kanjwal, Anil George, Sumeet K Mainigi[show abstract] [hide abstract]
ABSTRACT: Supraventricular tachycardia (SVT) is a common disorder which is associated with significant morbidity due to recurrent symptoms and multiple hospital visits. With advancements in mapping and ablation technology, most of the patients with SVT are now treated with radiofrequency ablation. However, for the procedure to be highly effective and safe it is imperative that the mechanism of tachycardia be understood accurately. The current paper reviews various tachycardia features and maneuvers that help to correctly establish the mechanism of various narrow complex SVTs.Journal of Innovations in cardiac rhythm management. 04/2013; -
Article: Economical selection of syncope patients for permanent cardiac pacing: a tilted view.
Blair Paul Grubb, Khalil KanjwalHeart (British Cardiac Society) 03/2013; · 4.22 Impact Factor -
Article: Controversies in the management of the renal artery stenosis.
Khalil Kanjwal, Vincent M Figueredo[show abstract] [hide abstract]
ABSTRACT: Optimal management of renal artery stenosis has continued to remain elusive. The previous non randomized studies and registry data suggested a benefit of renal artery stenting. However, the recently completed randomized studies comparing renal stenting to medical management failed to show any benefit. These studies had some flaws in their design and methodology. In an appropriately selected patient population renal artery stenting may have a role. In addition, there might be some role of adjunctive therapies like antiplatelet medications and embolic protection. This review summarizes the current literature on this controversial topic.Cardiology journal 01/2013; 20(1):11-6. · 1.31 Impact Factor -
Article: Sympathoadrenal imbalance and beta-blockers revisited.
Khalil Kanjwal, Joseph E MarineHeart rhythm: the official journal of the Heart Rhythm Society 08/2012; · 4.56 Impact Factor -
SourceAvailable from: Khalil Kanjwal
Dataset: Defibrillation Threshold Testing: A Primer
Khalil Kanjwal, Sumeet K Mainigi[show abstract] [hide abstract]
ABSTRACT: Implantable cardioverter-defibrillators lower mortality in appropriately selected patients. Defibrillation threshold (DFT) testing has traditionally been an inherent part of the implant procedure. Emerging data have begun to question the safety, benefits, and necessity of routine DFT testing. In this review we discuss defibrillation, outline the risks and benefits of DFT testing and outline an algorithm for treating patients with an elevated DFT.